STE Financial Statements & Analysis
Complete financial statements for STE including income statement, balance sheet, and cash flow statement. Analyze STE's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
55
Neutral
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
6.2% ↑
Net Income
62.5% ↑
Gross Margin
1.1% ↑
Operating Margin
-2.4% ↓
Balance Sheet
Current Ratio
-36.5% ↓
Debt to Equity
-37.9% ↑
Asset Turnover
15.8% ↑
Cash Flow
Operating Cash Flow
18.0% ↑
Net Cash Flow
-2541.7% ↓
Free Cash Flow
26.9% ↑
Cash Flow to Debt
81.2% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 5.14B | 5.46B | 6.2% | |
| Gross Profit | 2.24B | 2.40B | 7.4% | |
| Operating Income | 836.12M | 866.64M | 3.7% | |
| Net Income | 378.24M | 614.64M | 62.5% | |
| EPS | 3.83 | 6.24 | 62.9% | |
| EBITDA | 1.41B | 1.36B | 3.8% | |
| Gross Margin | 43.52% | 44.01% | 1.1% | |
| Operating Margin | 16.27% | 15.87% | 2.4% | |
| Net Income Margin | 7.36% | 11.26% | 53.0% | |
| R&D Expenses | 103.68M | 107.65M | 3.8% |
Income Statement Full Table
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 5.46B | 5.14B | 4.54B | 4.59B | 3.11B |
| Gross Profit | 2.40B | 2.24B | 1.98B | 2.02B | 1.34B |
| Operating Income | 866.64M | 836.12M | 791.10M | 477.81M | 323.30M |
| Net Income | 614.64M | 378.24M | 107.03M | 243.89M | 397.40M |
| EPS | 6.24 | 3.83 | 1.07 | 2.5 | 4.66 |
| EBITDA | 1.36B | 1.41B | 1.34B | 1.01B | 800.33M |
| Gross Margin | 44.01% | 43.52% | 43.66% | 43.98% | 43.22% |
| Operating Margin | 15.87% | 16.27% | 17.44% | 10.42% | 10.40% |
| Net Income Margin | 11.26% | 7.36% | 2.36% | 5.32% | 12.79% |
| R&D Expenses | 107.65M | 103.68M | 98.48M | 87.94M | 66.33M |